About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Utility of VI-RADS in Diagnosis of MIBC | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT05097404

Clinical Utility of VI-RADS in Diagnosis of MIBC

Bladder Cancer (BCa) is the 9th most common cancer worldwide. In general, BCa is presented as a non-muscle invasive bladder cancer (NMIBC) in 70% of patients and treated with transurethral resection o...

Lead sponsor: Samsung Medical Center•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

Samsung Medical Center

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•older than 18 years
•primary bladder cancer in cystoscopy
•suitable for MRI and TUR-BT
•agreement to participate in the study and signing of an informed consent form

Exclusion Criteria

•history of TUR-BT
•previous radiation and/or chemotherapy for bladder cancer
•Not suitable for MRI or TUR-BT

Related studies

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

NCT05334069 · Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and more

Supporting Sexual Health in Bladder Cancer Patients: A Sequential Mixed-Methods Intervention Study

NCT07339761 · Bladder Cancer, Non-Muscle-Invasive Bladder Cancer (NMIBC), and more

RECRUITINGPhase 1

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

NCT06529822 · Muscle-Invasive Bladder Carcinoma, Gastroesophageal Adenocarcinoma

Interest of Late Images for the Assessment of Extensions in 18FGD PET-CT of Muscle-Invasive Bladder Cancers

NCT06537960 · Muscle-Invasive Bladder Carcinoma, Bladder Cancer

RECRUITINGEARLY Phase 1

Prophylactic Antibiotics in Cystectomy With Diversion

NCT06190197 · Muscle-Invasive Bladder Carcinoma, Radical Cystectomy, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 28, 2021Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment73

Start dateSep 2021

Last updatedOct 28, 2021

Condition

Radical Cystectomy Muscle-Invasive Bladder Carcinoma Multiparametric MRI Vesical Imaging Report and Data System

Locations shown

Samsung Medical Center

Seoul

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 28, 2021Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions